Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells
/
mega-study
PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells